Eric R. Olson
Impact in
- Endocrinology top 2%
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
- Genetics 25
- Bacterial Genetics and Biotechnology 22
- Co-authors
- David I. Friedman (8 shared papers)Melody N. Neely (3 shared papers)Peter D. J. Grootenhuis (3 shared papers)Paul A. Negulescu (3 shared papers)Sabine Hadidaꝉ (3 shared papers)Fredrick Van Goor (3 shared papers)Melissa A. Ashlock (4 shared papers)Jeffrey H. Stack (2 shared papers)
- Journals
- Journal of Bacteriology (9 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Research (3 papers)Molecular Microbiology (3 papers)Cell (2 papers)
- Partner nations
- United StatesCanadaCzechia
In The Last Decade
Eric R. Olson
59 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology 269
- Molecular Medicine 239
- Genetics 1.3k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 2.5k
Countries citing papers authored by Eric R. Olson
This map shows the geographic impact of Eric R. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. Olson more than expected).
Fields of papers citing papers by Eric R. Olson
This network shows the impact of papers produced by Eric R. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. Olson. The network helps show where Eric R. Olson may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric R. Olson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 Hit paper breakdown → | 2011 | 831 |
| 2 | 2006 | 407 | |
| 3 | 2014 | 309 | |
| 4 | 2006 | 217 | |
| 5 | 1984 | 213 | |
| 6 | 1993 | 188 | |
| 7 | 1992 | 178 | |
| 8 | 1996 | 158 | |
| 9 | 2006 | 111 | |
| 10 | 1983 | 108 | |
| 11 | 2010 | 103 | |
| 12 | 1982 | 97 | |
| 13 | 1996 | 92 | |
| 14 | 1991 | 92 | |
| 15 | 1997 | 91 | |
| 16 | 1994 | 88 | |
| 17 | 1999 | 73 | |
| 18 | 2006 | 72 | |
| 19 | 1994 | 70 | |
| 20 | 2006 | 69 |
About Eric R. Olson
Eric R. Olson is a scholar working on Genetics, Molecular Medicine, Molecular Biology, Ecology and Applied Microbiology and Biotechnology, having authored 60 papers that have together received 4.3k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (22 papers), RNA and protein synthesis mechanisms (16 papers), Bacteriophages and microbial interactions (12 papers), RNA modifications and cancer (6 papers), DNA Repair Mechanisms (5 papers), Cystic Fibrosis Research Advances (5 papers), Protein Degradation and Inhibitors (4 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Endocrinology (269 citations), Molecular Medicine (239 citations), Genetics (1.3k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Molecular Biology (2.5k citations). Eric R. Olson has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include David I. Friedman, Melody N. Neely, Peter D. J. Grootenhuis, Paul A. Negulescu, Sabine Hadidaꝉ, Fredrick Van Goor, Melissa A. Ashlock, Jeffrey H. Stack, Kimberly Straley and Mark A. Miller. Their work appears in journals such as Journal of Bacteriology, Proceedings of the National Academy of Sciences, Cancer Research, Molecular Microbiology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.